Beconase AQ
Beconase AQ

21.25
For patients managing respiratory conditions, this generic medicine mimics natural glucocorticoid action. Reduces swelling within nasal passages and promotes long-term airway comfort.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Beclomethasone dipropionate
Reference Brand
Beclomethasone dipropionate
Product Origin
Generic Alternative
Reference Manufacturer
GlaxoSmithKline
Product Form
Inhaler
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care
Product Category
Glucocorticoid
Pharmacological Class
Corticosteroid Nasal Spray
Clinical Indications
Manufacturer Description
Utilized to manage nasal congestion and nasal polyps to alleviate chronic sinus blockage and support open passages.
Mechanism of Action
Inhibits local leukocyte migration and decreases inflammatory signaling within nasal mucosal tissues to relieve chronic congestion.
Route of Administration
Nasal
Onset Time
3–5 days
Duration
12 hours
Contraindications
Hypersensitivity to beclomethasone
Severe Adverse Events
Nasal septal ulceration — requires immediate medical attention
Common Side Effects
Nasal irritation, Sneezing, Throat burning
Uncommon Side Effects
Epistaxis, Headache, Taste disturbance
Pregnancy Safety Warnings
TGA Category C: Limited clinical documentation. Breastfeeding: Use caution.
Age Restrictions
Approved for pediatric patients over six years of age and adults.
Storage Guidelines
Store below 25°C.
Information related to Beconase AQ is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to purchase Quit Smoking Australia - Campral Australia